GlassScriptPhysician profile
James Shuhan Lin
NPI 1073000923
$9,620.63
in general payments reported to CMS, 2019-2025
13 companies · $5,542 in 2025
The $5,542 reported for 2025 was more than what 92% of Surgery of The Hand (Surgery) providers received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $561 · 2021: $1,217 · 2022: $1,250 · 2023: $583 · 2024: $468 · 2025: $5,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,173 · Food and Beverage: $1,800 · Education: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,173.21 |
| Food and Beverage | $1,800.12 |
| Education | $619.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $4,923.19 | 2024-2025 | Aptus |
| Cdc Medical LLC | $2,961.00 | 2019-2022 | |
| Acumed LLC | $701.11 | 2025 | Acumed, Innate Implant |
| Axogen | $372.75 | 2023 | Avance Nerve Graft |
| Integra Lifesciences Corporation | $178.43 | 2023 | Tenoglide |
| Trimed, INC. | $101.59 | 2024 | |
| Checkpoint Surgical, INC | $89.61 | 2024 | Checkpoint Stimulators |
| Stryker Corporation | $71.88 | 2023-2024 | Variax |
| Alnylam Pharmaceuticals INC. | $67.50 | 2024 | Onpattro |
| Arthrosurface Incorporated | $64.23 | 2025 | Wristmotion Wrist Hemiarthroplasty System |
| Si-Bone, INC. | $49.69 | 2022 | |
| Endo Pharmaceuticals INC. | $22.59 | 2024 | Xiaflex |
| Innovation Technologies INC | $17.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.